{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:20:17Z","timestamp":1790601617408,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05753-8","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:16:26Z","timestamp":1737443786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diversity of central nervous system manifestations in Sjogren\u2019s Disease: a case-based review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-4490","authenticated-orcid":false,"given":"Marta","family":"Jask\u00f3lska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0860-3998","authenticated-orcid":false,"given":"Magdalena","family":"Rytlewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-6227","authenticated-orcid":false,"given":"Natalia Aleksandra","family":"Du\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6463-4196","authenticated-orcid":false,"given":"Mi\u0142osz","family":"Ulanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-1937","authenticated-orcid":false,"given":"Mariusz","family":"Kwarciany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-5954","authenticated-orcid":false,"given":"Mariusz Stanis\u0142aw","family":"Wiglusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-8454","authenticated-orcid":false,"given":"Wies\u0142aw Jerzy","family":"Cuba\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-8786","authenticated-orcid":false,"given":"Micha\u0142","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"5753_CR1","doi-asserted-by":"publisher","unstructured":"Fox RI. (2005) Sj\u00f6gren\u2019s syndrome. Lancet. 366(9482):321\u2009\u2212\u200931. https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","DOI":"10.1016\/S0140-6736(05)66990-5"},{"key":"5753_CR2","doi-asserted-by":"publisher","unstructured":"Mariette, X., & Criswell, L. A. (2018). Primary Sj\u00f6gren\u2019s Syndrome. The New England journal of medicine, 378(10):931\u2013939. https:\/\/doi.org\/10.1056\/NEJMcp1702514","DOI":"10.1056\/NEJMcp1702514"},{"key":"5753_CR3","doi-asserted-by":"publisher","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T (2017). The Diagnosis and Treatment of Sj\u00f6gren\u2019s Syndrome. Dtsch Arztebl Int. 114(20):354\u2013361. https:\/\/doi.org\/10.3238\/arztebl.2017.0354","DOI":"10.3238\/arztebl.2017.0354"},{"key":"5753_CR4","doi-asserted-by":"publisher","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010); EULAR Sj\u00f6gren\u2019s Task Force. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 69(6):1103-9. https:\/\/doi.org\/10.1136\/ard.2009.110619","DOI":"10.1136\/ard.2009.110619"},{"key":"5753_CR5","doi-asserted-by":"publisher","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Solans R, Camps MT, Casanovas A, Sope\u00f1a B, D\u00edaz-L\u00f3pez B, Rasc\u00f3n FJ, Qanneta R, Fraile G, P\u00e9rez-Alvarez R, Callejas JL, Ripoll M, Pinilla B, Akasbi M, Fonseca E, Canora J, Nadal ME, de la Red G, Fern\u00e1ndez-Regal I, Jim\u00e9nez-Heredia I, Bosch JA, Ayala MD, Morera-Morales L, Maure B, Mera A, Ramentol M, Retamozo S, Kostov B; SS Study Group (2014); Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI). Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford). 53(2):321\u2009\u2212\u200931. https:\/\/doi.org\/10.1093\/rheumatology\/ket349","DOI":"10.1093\/rheumatology\/ket349"},{"key":"5753_CR6","doi-asserted-by":"publisher","unstructured":"Ye W, Chen S, Huang X, Qin W, Zhang T, Zhu X, Zhu X, Lin C, Wang X (2018). Clinical features and risk factors of neurological involvement in Sj\u00f6gren\u2019s syndrome. BMC Neurosci. 19(1):26. https:\/\/doi.org\/10.1186\/s12868-018-0427-y","DOI":"10.1186\/s12868-018-0427-y"},{"key":"5753_CR7","doi-asserted-by":"publisher","unstructured":"M\u00f3dis LV, Aradi Z, Horv\u00e1th IF, Bencze J, Papp T, Emri M, Ber\u00e9nyi E, Bug\u00e1n A, Sz\u00e1nt\u00f3 A (2022). Central Nervous System Involvement in Primary Sj\u00f6gren\u2019s Syndrome: Narrative Review of MRI Findings. Diagnostics (Basel). 13(1):14. https:\/\/doi.org\/10.3390\/diagnostics13010014","DOI":"10.3390\/diagnostics13010014"},{"key":"5753_CR8","doi-asserted-by":"publisher","unstructured":"Perzy\u0144ska-Mazan J, Ma\u015bli\u0144ska M, Gasik R (2018). Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Reumatologia. 56(2):99\u2013105. https:\/\/doi.org\/10.5114\/reum.2018.75521","DOI":"10.5114\/reum.2018.75521"},{"key":"5753_CR9","doi-asserted-by":"publisher","unstructured":"Fauchais AL, Magy L, Vidal E (2012). Central and peripheral neurological complications of primary Sj\u00f6gren\u2019s syndrome. Presse Med. 41(9 Pt 2):e485-93. https:\/\/doi.org\/10.1016\/j.lpm.2012.06.002","DOI":"10.1016\/j.lpm.2012.06.002"},{"key":"5753_CR10","doi-asserted-by":"publisher","unstructured":"Barsottini OGP, Moraes MPM, Fraiman PHA, Marussi VHR, Souza AWS, Braga Neto P, Spitz M (2023). Sjogren\u2019s syndrome: a neurological perspective. Arq Neuropsiquiatr. 81(12):1077\u20131083. https:\/\/doi.org\/10.1055\/s-0043-1777105","DOI":"10.1055\/s-0043-1777105"},{"key":"5753_CR11","doi-asserted-by":"publisher","unstructured":"Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A (2016). Epidemiology of neurological manifestations in Sj\u00f6gren\u2019s syndrome: data from the French ASSESS Cohort. RMD Open. 2(1):e000179. https:\/\/doi.org\/10.1136\/rmdopen-2015-000179","DOI":"10.1136\/rmdopen-2015-000179"},{"key":"5753_CR12","doi-asserted-by":"publisher","unstructured":"Morreale M, Marchione P, Giacomini P, Pontecorvo S, Marianetti M, Vento C, Tinelli E, Francia A (2014). Neurological involvement in primary Sj\u00f6gren syndrome: a focus on central nervous system. PLoS One. 9(1):e84605. https:\/\/doi.org\/10.1371\/journal.pone.0084605","DOI":"10.1371\/journal.pone.0084605"},{"key":"5753_CR13","doi-asserted-by":"publisher","unstructured":"Hassin-Baer S, Levy Y, Langevitz P, Nakar S, Ehrenfeld M (2007). Anti-beta2-glycoprotein I in Sjogren\u2019s syndrome is associated with parkinsonism. Clin Rheumatol. 26(5):743-7. https:\/\/doi.org\/10.1007\/s10067-006-0398-8","DOI":"10.1007\/s10067-006-0398-8"},{"key":"5753_CR14","doi-asserted-by":"publisher","unstructured":"Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004). Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine (Baltimore). 83(5):280\u2013291 https:\/\/doi.org\/10.1097\/01.md.0000141099.53742.16","DOI":"10.1097\/01.md.0000141099.53742.16"},{"key":"5753_CR15","doi-asserted-by":"publisher","unstructured":"Khalayli N, Kudsi M (2022). Sj\u00f6gren\u2019s syndrome with bipolar disorder, case report. Ann Med Surg (Lond). 80:104243. https:\/\/doi.org\/10.1016\/j.amsu.2022.104243","DOI":"10.1016\/j.amsu.2022.104243"},{"key":"5753_CR16","doi-asserted-by":"publisher","unstructured":"Pelizza L, Bonacini F, Ferrari A (2010). Psychiatric disorder as clinical presentation of primary Sj\u00f6gren\u2019s syndrome: two case reports. Ann Gen Psychiatry. 9:12. https:\/\/doi.org\/10.1186\/1744-859X-9-12","DOI":"10.1186\/1744-859X-9-12"},{"key":"5753_CR17","doi-asserted-by":"publisher","unstructured":"Smiyan S, Komorovsky R, Koshak B, Duve K, Shkrobot S (2024). Central nervous system manifestations in rheumatic diseases. Rheumatol Int. 44(10):1803\u20131812. https:\/\/doi.org\/10.1007\/s00296-024-05679-1","DOI":"10.1007\/s00296-024-05679-1"},{"key":"5753_CR18","doi-asserted-by":"publisher","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017); International Sj\u00f6gren\u2019s Syndrome Criteria Working Group. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859","DOI":"10.1002\/art.39859"},{"key":"5753_CR19","doi-asserted-by":"publisher","unstructured":"Both T, Dalm VA, van Hagen PM, van Daele PL (2017). Reviewing primary Sj\u00f6gren\u2019s syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment. Int J Med Sci. 14(3):191\u2013200. https:\/\/doi.org\/10.7150\/ijms.17718","DOI":"10.7150\/ijms.17718"},{"key":"5753_CR20","doi-asserted-by":"publisher","unstructured":"Patel R, Shahane A (2014). The epidemiology of Sj\u00f6gren\u2019s syndrome. Clin Epidemiol. 6:247\u2009\u2212\u200955. https:\/\/doi.org\/10.2147\/CLEP.S47399","DOI":"10.2147\/CLEP.S47399"},{"key":"5753_CR21","doi-asserted-by":"publisher","unstructured":"Carteron NL, Bootsma H, Kroese FGM, Vissink A, Dumusc A, Bowman SJ. Clinical Aspects of Sj\u00f6gren\u2019s. In Wallace DJ, Hahn BH, editors, Dubois\u2019 Lupus Erythematosus and Related Syndromes. 9th ed. Elsevier. 2018. p. 566\u2013578. https:\/\/doi.org\/10.1016\/B978-0-323-47927-1.00045-1","DOI":"10.1016\/B978-0-323-47927-1.00045-1"},{"key":"5753_CR22","doi-asserted-by":"publisher","unstructured":"Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C (2020). Current State of Knowledge on Primary Sj\u00f6gren\u2019s Syndrome, an Autoimmune Exocrinopathy. J Clin Med. 9(7):2299. https:\/\/doi.org\/10.3390\/jcm9072299","DOI":"10.3390\/jcm9072299"},{"key":"5753_CR23","doi-asserted-by":"publisher","unstructured":"Barroso B (2007). Primary Sj\u00f6gren\u2019s syndrome mimicking neuromyelitis optica. Eur J Intern Med. 18(6):507. https:\/\/doi.org\/10.1016\/j.ejim.2007.02.009","DOI":"10.1016\/j.ejim.2007.02.009"},{"key":"5753_CR24","doi-asserted-by":"publisher","unstructured":"Fujimoto K, Norikane T, Yamamoto Y, Takami Y, Murota M, Shimada H, Dobashi H, Nishiyama Y (2022). Cardiac Sarcoidosis Mimicking Lymphoma in a Patient With Sjogren\u2019s Syndrome. Korean Circ J. 52(9):715\u2013716. https:\/\/doi.org\/10.4070\/kcj.2022.0068","DOI":"10.4070\/kcj.2022.0068"},{"key":"5753_CR25","doi-asserted-by":"publisher","unstructured":"Kamogawa Y, Akita K, Sato H, Shirai T, Ishii T, Harigae H, Fujii H (2022). Sj\u00f6gren\u2019s Syndrome Presenting with Temporary Hemiplegia Mimicking Transient Ischemic Attack. Tohoku J Exp Med. 258(3):207\u2013211. https:\/\/doi.org\/10.1620\/tjem.2022.J079","DOI":"10.1620\/tjem.2022.J079"},{"key":"5753_CR26","doi-asserted-by":"publisher","unstructured":"McCrary HC, Faucett EA, Erman AB (2016). Immunoglobulin G4-related sclerosing disease Mimicking sjogren\u2019s syndrome: A case report. Laryngoscope. 126(10):2242-5. https:\/\/doi.org\/10.1002\/lary.26112","DOI":"10.1002\/lary.26112"},{"key":"5753_CR27","doi-asserted-by":"publisher","unstructured":"Matsuo K, Saburi M, Ishikawa H, Tei K, Hosokawa Y, Fujii C, Mizuno T, Nakagawa M (2013). Sj\u00f6gren syndrome presenting with encephalopathy mimicking Creutzfeldt-Jakob disease. J Neurol Sci. 326(1\u20132):100-3. https:\/\/doi.org\/10.1016\/j.jns.2013.01.005","DOI":"10.1016\/j.jns.2013.01.005"},{"key":"5753_CR28","doi-asserted-by":"publisher","unstructured":"Tuisku IS, Konttinen YT, Soinila S, Karma A, Tervo TM (2004). Neurosarcoidosis mimicking Sj\u00f6gren\u2019s syndrome. Acta Ophthalmol Scand. 82(5):599\u2013602. https:\/\/doi.org\/10.1111\/j.1600-0420.2004.00369.x","DOI":"10.1111\/j.1600-0420.2004.00369.x"},{"key":"5753_CR29","doi-asserted-by":"publisher","unstructured":"Konak HE, G\u00f6k K, Arma\u011fan B, G\u00fcven SC, Atalar E, Apayd\u0131n H, Mara\u015f Y, Erten \u015e (2023). Neurological Involvement in Patients with Primary Sj\u00f6gren\u2019s Syndrome: A Retrospective Cross-Sectional Study. Ann Indian Acad Neurol. 26(4):424\u2013430. https:\/\/doi.org\/10.4103\/aian.aian_138_23","DOI":"10.4103\/aian.aian_138_23"},{"key":"5753_CR30","doi-asserted-by":"publisher","unstructured":"Fan G, Dai F, Chen S, Sun Y, Qian H, Yang G, Liu Y, Shi G (2021). Neurological Involvement in Patients With Primary Sj\u00f6gren\u2019s Syndrome. J Clin Rheumatol. 27(2):50\u201355. https:\/\/doi.org\/10.1097\/RHU.0000000000001128","DOI":"10.1097\/RHU.0000000000001128"},{"key":"5753_CR31","doi-asserted-by":"publisher","unstructured":"Du\u0142ak NA, Rytlewska M, Jask\u00f3lska M, Chmielewski M (2024). A new perspective on vitamin B12 deficiency in rheumatology: a case-based review. Rheumatol Int. 44(4):737\u2013741. https:\/\/doi.org\/10.1007\/s00296-024-05539-y","DOI":"10.1007\/s00296-024-05539-y"},{"key":"5753_CR32","doi-asserted-by":"publisher","unstructured":"Seeliger T, Kramer E, Konen FF, Zehrfeld N, Beider S, Prenzler NK, G\u00f6decke V, Witte T, Skripuletz T, Ernst D (2023). Sj\u00f6gren\u2019s syndrome with and without neurological involvement. J Neurol. 270(6):2987\u20132996. https:\/\/doi.org\/10.1007\/s00415-023-11613-5","DOI":"10.1007\/s00415-023-11613-5"},{"key":"5753_CR33","doi-asserted-by":"publisher","unstructured":"Afzali AM, Moog P, Kalluri SR, Hofauer B, Knopf A, Kirschke JS, Hemmer B, Berthele A (2023). CNS demyelinating events in primary Sj\u00f6gren\u2019s syndrome: A single-center case series on the clinical phenotype. Front Neurol. 14:1128315. https:\/\/doi.org\/10.3389\/fneur.2023.1128315","DOI":"10.3389\/fneur.2023.1128315"},{"key":"5753_CR34","doi-asserted-by":"publisher","unstructured":"Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, Feggi L, Govoni M (2010). Central nervous system involvement in Sj\u00f6gren\u2019s syndrome: unusual, but not unremarkable\u2013clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford). 49(8):1540-9. https:\/\/doi.org\/10.1093\/rheumatology\/keq111","DOI":"10.1093\/rheumatology\/keq111"},{"key":"5753_CR35","doi-asserted-by":"publisher","unstructured":"Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E (2015). Frequent involvement of central nervous system in primary Sj\u00f6gren syndrome. Rheumatol Int. 35(2):289\u2009\u2212\u200994. https:\/\/doi.org\/10.1007\/s00296-014-3097-9","DOI":"10.1007\/s00296-014-3097-9"},{"key":"5753_CR36","doi-asserted-by":"publisher","unstructured":"Wang ZZ, Liu MS, Sun Z, Zhang XL, Zhang ML, Xiong K, Zhou F (2022). Risk of dementia or Parkinson\u2019s disease in the presence of Sj\u00f6gren\u2019s syndrome: A systematic review and meta-analysis. Front Integr Neurosci. 16:1027044. https:\/\/doi.org\/10.3389\/fnint.2022.1027044","DOI":"10.3389\/fnint.2022.1027044"},{"key":"5753_CR37","doi-asserted-by":"publisher","unstructured":"Hsu HC, Hou TY, Lin TM, Chang YS, Chen WS, Kuo PI, Lin YC, Chang CC, Chen JH (2020). Higher risk of Parkinson disease in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 39(10):2999\u20133007. https:\/\/doi.org\/10.1007\/s10067-020-05053-z","DOI":"10.1007\/s10067-020-05053-z"},{"key":"5753_CR38","doi-asserted-by":"publisher","unstructured":"Kchaou M, Ben Ali N, Hmida I, Fray S, Jamoussi H, Jalleli M, Echebbi S, Achouri A, Belal S (2015). Parkinsonism and Sj\u00f6gren\u2019s Syndrome: A Fortuitous Association or a Shared Immunopathogenesis? Case Rep Med. 2015:432910. https:\/\/doi.org\/10.1155\/2015\/432910","DOI":"10.1155\/2015\/432910"},{"key":"5753_CR39","doi-asserted-by":"publisher","unstructured":"Cr\u00e9ange A, Sedel F, Brugi\u00e8res P, Voisin MC, Degos JD (1997). Primary Sj\u00f6gren\u2019s syndrome presenting as progressive parkinsonian syndrome. Mov Disord. 12(1):121-3. https:\/\/doi.org\/10.1002\/mds.870120124","DOI":"10.1002\/mds.870120124"},{"key":"5753_CR40","doi-asserted-by":"publisher","unstructured":"Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994). Corticosteroid-responsive parkinsonism associated with primary Sj\u00f6gren\u2019s syndrome. Clin Neurol Neurosurg. 96(4):327\u2009\u2212\u200931. https:\/\/doi.org\/10.1016\/0303-8467(94)90124-4","DOI":"10.1016\/0303-8467(94)90124-4"},{"key":"5753_CR41","doi-asserted-by":"publisher","unstructured":"Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, Argyropoulou MI (2011). CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry. AJR Am J Roentgenol. 197(5):1207-12. https:\/\/doi.org\/10.2214\/AJR.10.5984","DOI":"10.2214\/AJR.10.5984"},{"key":"5753_CR42","unstructured":"Alhomoud IA, Bohlega SA, Alkawi MZ, Alsemari AM, Omer SM, Alsenani FM (2009). Primary Sjogren\u2019s syndrome with central nervous system involvement. Saudi Med J. 30(8):1067-72. PMID: 19668890."},{"key":"5753_CR43","doi-asserted-by":"publisher","unstructured":"Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R (2023). Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 42(2):443\u2013451. https:\/\/doi.org\/10.1007\/s10067-022-06448-w","DOI":"10.1007\/s10067-022-06448-w"},{"key":"5753_CR44","doi-asserted-by":"publisher","unstructured":"Morgen K, McFarland HF, Pillemer SR (2004). Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum. 34(3):623\u2009\u2212\u200930. https:\/\/doi.org\/10.1016\/j.semarthrit.2004.07.005","DOI":"10.1016\/j.semarthrit.2004.07.005"},{"key":"5753_CR45","doi-asserted-by":"publisher","unstructured":"Harboe E, Beyer MK, Greve OJ, G\u00f8ransson LG, Tjensvoll AB, Kval\u00f8y JT, Omdal R (2009). Cerebral white matter hyperintensities are not increased in patients with primary Sj\u00f6gren\u2019s syndrome. Eur J Neurol. 16(5):576\u2009\u2212\u200981. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02537.x","DOI":"10.1111\/j.1468-1331.2009.02537.x"},{"key":"5753_CR46","doi-asserted-by":"publisher","unstructured":"Pars K, Pul R, Schwenkenbecher P, S\u00fchs KW, Wurster U, Witte T, Bronzlik P, Stangel M, Skripuletz T (2017). Cerebrospinal Fluid Findings in Neurological Diseases Associated with Sj\u00f6gren\u2019s Syndrome. Eur Neurol. 77(1\u20132):91\u2013102. https:\/\/doi.org\/10.1159\/000454765","DOI":"10.1159\/000454765"},{"key":"5753_CR47","doi-asserted-by":"publisher","unstructured":"Tjensvoll AB, Lauvsnes MB, Zetterberg H, Kval\u00f8y JT, Kvivik I, Maroni SS, Greve OJ, Beyer MK, Hirohata S, Putterman C, Alves G, Harboe E, Blennow K, G\u00f8ransson LG, Omdal R (2021). Neurofilament light is a biomarker of brain involvement in lupus and primary Sj\u00f6gren\u2019s syndrome. J Neurol. 268(4):1385\u20131394. https:\/\/doi.org\/10.1007\/s00415-020-10290-y","DOI":"10.1007\/s00415-020-10290-y"},{"key":"5753_CR48","doi-asserted-by":"publisher","unstructured":"Castellazzi M, Candeloro R, Pugliatti M, Govoni M, Silvagni E, Bortoluzzi A (2024). Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review. Diagnostics (Basel). 14(3):242. https:\/\/doi.org\/10.3390\/diagnostics14030242","DOI":"10.3390\/diagnostics14030242"},{"key":"5753_CR49","doi-asserted-by":"publisher","unstructured":"Alexander EL, Provost TT, Sanders ME, Frank MM, Joiner KA (1988). Serum complement activation in central nervous system disease in Sj\u00f6gren\u2019s syndrome. Am J Med. 85(4):513-8. https:\/\/doi.org\/10.1016\/s0002-9343(88)80087-1","DOI":"10.1016\/s0002-9343(88)80087-1"},{"key":"5753_CR50","doi-asserted-by":"publisher","unstructured":"Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H (2011). Clinical manifestations of neurological involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 30(4):485\u2009\u2212\u200990. https:\/\/doi.org\/10.1007\/s10067-010-1458-7","DOI":"10.1007\/s10067-010-1458-7"},{"key":"5753_CR51","doi-asserted-by":"publisher","unstructured":"Tetsuka S, Suzuki T, Ogawa T, Hashimoto R, Kato H (2021). Anti-Ro\/SSA Antibodies May Be Responsible for Cerebellar Degeneration in Sjogren\u2019s Syndrome. J Clin Med Res. 13(2):113\u2013120. https:\/\/doi.org\/10.14740\/jocmr4429","DOI":"10.14740\/jocmr4429"},{"key":"5753_CR52","doi-asserted-by":"publisher","unstructured":"S\u00e8ve P, Gachon E, Petiot P, Stankovic K, Charhon A, Broussolle C (2007). Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int. 28(2):175-7. https:\/\/doi.org\/10.1007\/s00296-007-0396-4","DOI":"10.1007\/s00296-007-0396-4"},{"key":"5753_CR53","doi-asserted-by":"publisher","unstructured":"Govoni M, Padovan M, Rizzo N, Trotta F (2001). CNS involvement in primary Sj\u00f6gren\u2019s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs. 15(8):597\u2013607. https:\/\/doi.org\/10.2165\/00023210-200115080-00003","DOI":"10.2165\/00023210-200115080-00003"},{"key":"5753_CR54","doi-asserted-by":"publisher","unstructured":"Soliotis FC, Mavragani CP, Moutsopoulos HM (2004). Central nervous system involvement in Sjogren\u2019s syndrome. Ann Rheum Dis. 63(6):616\u2009\u2212\u200920. https:\/\/doi.org\/10.1136\/ard.2003.019497","DOI":"10.1136\/ard.2003.019497"},{"key":"5753_CR55","doi-asserted-by":"publisher","unstructured":"Mehta P, Zimba O, Gasparyan AY, Seiil B, Yessirkepov M (2023). Ethics Committees: Structure, Roles, and Issues. J Korean Med Sci. 38(25):e198. https:\/\/doi.org\/10.3346\/jkms.2023.38.e198","DOI":"10.3346\/jkms.2023.38.e198"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05753-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:59:24Z","timestamp":1739314764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05753-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["5753"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05753-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Bioethics Committee of Medical University of Gda\u0144sk (Date 06.07.2023\/No. KB\/373\/2023).We have obtained informed written consent from the patients to be described in our article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None of the authors has any conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors approved the final version of the manuscript and take full responsibility for the integrity and accuracy of all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that they have not used any type of artificial intelligence for the writing or editing of this manuscript, nor for the creation of images.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}